Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0002159407-26-000004

Options or other derivatives

  • Director acquired 17,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bonuccelli Catherine M. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-09 Grant or award : show line 1 in the form Director Stock Option (Right to Buy) +17,000 17,000 D
Loading xslF345X06/form4-11122026_041103.xml…